34.99
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt RARE?
Forum
Prognose
Aktiensplit
Ultragenyx Pharmaceutical Inc Aktie (RARE) Neueste Nachrichten
Chart based analysis of Ultragenyx Pharmaceutical Inc. trendsJuly 2025 Institutional & Growth Focused Entry Reports - newser.com
Can Ultragenyx Pharmaceutical Inc. stock weather global recession2025 Volatility Report & Consistent Growth Stock Picks - newser.com
How risky is Ultragenyx Pharmaceutical Inc. stock nowJuly 2025 Price Swings & Verified Momentum Stock Watchlist - newser.com
Can Ultragenyx Pharmaceutical Inc. (UP0) stock hold up in economic slowdownRate Cut & Weekly Breakout Watchlists - newser.com
Will Ultragenyx Pharmaceutical Inc. stock benefit from upcoming earnings reportsJuly 2025 Trade Ideas & Community Verified Trade Alerts - newser.com
Will Ultragenyx Pharmaceutical Inc. see short term momentumRisk Management & Long Hold Capital Preservation Tips - newser.com
Is Ultragenyx Pharmaceutical Inc. stock attractive after correction2025 Earnings Impact & Reliable Price Action Trade Plans - newser.com
Will Ultragenyx Pharmaceutical Inc. stock remain a Wall Street favorite2025 Market Outlook & Fast Entry and Exit Trade Plans - newser.com
Earnings visualization tools for Ultragenyx Pharmaceutical Inc.Portfolio Profit Report & Growth Oriented Trade Recommendations - newser.com
What hedge fund moves indicate for Ultragenyx Pharmaceutical Inc. (UP0) stockJuly 2025 Summary & Low Risk High Reward Ideas - newser.com
Why Ultragenyx Pharmaceutical Inc. stock appeals to dividend seekersWeekly Stock Recap & AI Enhanced Market Trend Forecasts - newser.com
Is Ultragenyx Pharmaceutical Inc. stock dividend yield sustainableJuly 2025 Analyst Calls & Technical Entry and Exit Alerts - newser.com
Can Ultragenyx Pharmaceutical Inc. stock deliver sustainable ROE2025 AllTime Highs & Low Risk Growth Stock Ideas - newser.com
Can Ultragenyx Pharmaceutical Inc. stock sustain revenue growthOptions Play & Free Community Supported Trade Ideas - newser.com
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):